vs

Side-by-side financial comparison of Ramaco Resources, Inc. (METC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Ramaco Resources, Inc. is the larger business by last-quarter revenue ($121.0M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-17.5M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -22.7%).

Ramaco Resources, Inc. is a U.S.-based mining company focused on high-grade metallurgical coal production. It operates mining assets across the Appalachian region, supplying products to global steel manufacturing and industrial clients, with core operations centered on sustainable low-cost metallurgical coal extraction and distribution.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

METC vs PBYI — Head-to-Head

Bigger by revenue
METC
METC
1.6× larger
METC
$121.0M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+55.4% gap
PBYI
27.7%
-27.7%
METC
More free cash flow
PBYI
PBYI
$31.9M more FCF
PBYI
$14.4M
$-17.5M
METC
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-22.7%
METC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
METC
METC
PBYI
PBYI
Revenue
$121.0M
$75.5M
Net Profit
$-13.3M
Gross Margin
15.8%
69.3%
Operating Margin
-12.0%
22.7%
Net Margin
-11.0%
Revenue YoY
-27.7%
27.7%
Net Profit YoY
-5468.2%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
METC
METC
PBYI
PBYI
Q4 25
$75.5M
Q3 25
$121.0M
$54.5M
Q2 25
$153.0M
$52.4M
Q1 25
$134.7M
$46.0M
Q4 24
$170.9M
$59.1M
Q3 24
$167.4M
$80.5M
Q2 24
$155.3M
$47.1M
Q1 24
$172.7M
$43.8M
Net Profit
METC
METC
PBYI
PBYI
Q4 25
Q3 25
$-13.3M
$8.8M
Q2 25
$-14.0M
$5.9M
Q1 25
$-9.5M
$3.0M
Q4 24
$3.9M
Q3 24
$-239.0K
$20.3M
Q2 24
$5.5M
$-4.5M
Q1 24
$2.0M
$-4.8M
Gross Margin
METC
METC
PBYI
PBYI
Q4 25
69.3%
Q3 25
15.8%
77.7%
Q2 25
12.3%
76.5%
Q1 25
15.2%
77.1%
Q4 24
20.4%
76.4%
Q3 24
19.5%
63.9%
Q2 24
21.0%
77.4%
Q1 24
19.1%
75.5%
Operating Margin
METC
METC
PBYI
PBYI
Q4 25
22.7%
Q3 25
-12.0%
17.6%
Q2 25
-9.1%
12.7%
Q1 25
-8.9%
8.7%
Q4 24
3.7%
22.6%
Q3 24
1.0%
27.4%
Q2 24
3.5%
-4.6%
Q1 24
1.9%
-5.3%
Net Margin
METC
METC
PBYI
PBYI
Q4 25
Q3 25
-11.0%
16.2%
Q2 25
-9.1%
11.2%
Q1 25
-7.0%
6.5%
Q4 24
2.3%
Q3 24
-0.1%
25.2%
Q2 24
3.6%
-9.6%
Q1 24
1.2%
-11.0%
EPS (diluted)
METC
METC
PBYI
PBYI
Q4 25
$0.26
Q3 25
$0.17
Q2 25
$0.12
Q1 25
$0.06
Q4 24
$0.06
$0.40
Q3 24
$-0.03
$0.41
Q2 24
$0.08
$-0.09
Q1 24
$0.00
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
METC
METC
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$193.8M
$97.5M
Total DebtLower is stronger
$116.3M
$22.7M
Stockholders' EquityBook value
$526.9M
$130.3M
Total Assets
$849.7M
$216.3M
Debt / EquityLower = less leverage
0.22×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
METC
METC
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$193.8M
$94.4M
Q2 25
$28.1M
$96.0M
Q1 25
$43.5M
$93.2M
Q4 24
$33.0M
$101.0M
Q3 24
$22.9M
$96.7M
Q2 24
$27.6M
$96.8M
Q1 24
$30.5M
$107.2M
Total Debt
METC
METC
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$116.3M
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$88.2M
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
METC
METC
PBYI
PBYI
Q4 25
$130.3M
Q3 25
$526.9M
$115.3M
Q2 25
$347.4M
$104.7M
Q1 25
$355.2M
$97.1M
Q4 24
$362.8M
$92.1M
Q3 24
$361.8M
$71.1M
Q2 24
$366.1M
$48.5M
Q1 24
$372.3M
$51.0M
Total Assets
METC
METC
PBYI
PBYI
Q4 25
$216.3M
Q3 25
$849.7M
$202.9M
Q2 25
$674.6M
$194.9M
Q1 25
$685.7M
$196.2M
Q4 24
$674.7M
$213.3M
Q3 24
$645.4M
$220.7M
Q2 24
$659.2M
$205.0M
Q1 24
$674.0M
$214.1M
Debt / Equity
METC
METC
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.22×
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.24×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
METC
METC
PBYI
PBYI
Operating Cash FlowLast quarter
$-1.4M
$14.4M
Free Cash FlowOCF − Capex
$-17.5M
$14.4M
FCF MarginFCF / Revenue
-14.5%
19.1%
Capex IntensityCapex / Revenue
13.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.7M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
METC
METC
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$-1.4M
$9.7M
Q2 25
$-4.3M
$14.1M
Q1 25
$26.0M
$3.6M
Q4 24
$15.7M
$15.6M
Q3 24
$37.4M
$11.0M
Q2 24
$34.4M
$1.0M
Q1 24
$25.2M
$11.2M
Free Cash Flow
METC
METC
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$-17.5M
$9.7M
Q2 25
$-19.8M
$14.1M
Q1 25
$7.6M
$3.6M
Q4 24
$5.1M
$15.6M
Q3 24
$25.6M
$11.0M
Q2 24
$20.3M
$1.0M
Q1 24
$6.5M
FCF Margin
METC
METC
PBYI
PBYI
Q4 25
19.1%
Q3 25
-14.5%
17.7%
Q2 25
-13.0%
26.8%
Q1 25
5.6%
7.7%
Q4 24
3.0%
26.4%
Q3 24
15.3%
13.7%
Q2 24
13.1%
2.1%
Q1 24
3.7%
Capex Intensity
METC
METC
PBYI
PBYI
Q4 25
0.0%
Q3 25
13.3%
0.0%
Q2 25
10.2%
0.0%
Q1 25
13.7%
0.1%
Q4 24
6.2%
0.0%
Q3 24
7.0%
0.0%
Q2 24
9.1%
0.0%
Q1 24
10.8%
0.0%
Cash Conversion
METC
METC
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
4.06×
Q3 24
0.54×
Q2 24
6.21×
Q1 24
12.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

METC
METC

Export Coal Revenues$73.0M60%
Domestic Coal Revenues$48.0M40%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons